Biofilm is the trigger for the majority of infections caused by the ability of microorganisms to adhere to tissues and medical devices. Microbial cells embedded in the biofilm matrix are highly tolerant to antimicrobials and escape the host immune system. Thus, the refractory nature of biofilmrelated infections (BRIs) still represents a great challenge for physicians and is a serious health threat worldwide. Despite its importance, the microbiological diagnosis of a BRI is still difficult and not routinely assessed in clinical microbiology. Moreover, biofilm bacteria are up to 100–1000 times less susceptible to antibiotics than their planktonic counterpart. Consequently, conventional antibiograms might not be representative of the bacterial drug susceptibility in vivo. The timely recognition of a BRI is a crucial step to directing the most appropriate biofilm-targeted antimicrobial strategy.

The Current Knowledge on the Pathogenesis of Tissue and Medical Device-Related Biofilm Infections / Di Domenico, E. G.; Oliva, A.; Guembe, M.. - In: MICROORGANISMS. - ISSN 2076-2607. - 10:7(2022). [10.3390/microorganisms10071259]

The Current Knowledge on the Pathogenesis of Tissue and Medical Device-Related Biofilm Infections

Di Domenico E. G.;Oliva A.;
2022

Abstract

Biofilm is the trigger for the majority of infections caused by the ability of microorganisms to adhere to tissues and medical devices. Microbial cells embedded in the biofilm matrix are highly tolerant to antimicrobials and escape the host immune system. Thus, the refractory nature of biofilmrelated infections (BRIs) still represents a great challenge for physicians and is a serious health threat worldwide. Despite its importance, the microbiological diagnosis of a BRI is still difficult and not routinely assessed in clinical microbiology. Moreover, biofilm bacteria are up to 100–1000 times less susceptible to antibiotics than their planktonic counterpart. Consequently, conventional antibiograms might not be representative of the bacterial drug susceptibility in vivo. The timely recognition of a BRI is a crucial step to directing the most appropriate biofilm-targeted antimicrobial strategy.
2022
biofilm; clinical impact; devices; pathogenesis; tissues
01 Pubblicazione su rivista::01a Articolo in rivista
The Current Knowledge on the Pathogenesis of Tissue and Medical Device-Related Biofilm Infections / Di Domenico, E. G.; Oliva, A.; Guembe, M.. - In: MICROORGANISMS. - ISSN 2076-2607. - 10:7(2022). [10.3390/microorganisms10071259]
File allegati a questo prodotto
File Dimensione Formato  
Di Domenico_Current_2022.pdf

accesso aperto

Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Creative commons
Dimensione 1.34 MB
Formato Adobe PDF
1.34 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1650719
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 38
  • ???jsp.display-item.citation.isi??? 35
social impact